Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy

Mehmet Cilingiroglu, Venkata Chilakapati, Stephanie Hope Dunlap, Massoud A. Leesar

Research output: Contribution to journalArticle

Abstract

Cardiac allograft vasculopathy (CAV) is the most common cause of long-term graft failure after heart transplantation. In the absence of a specific treatment for this condition, percutaneous coronary revascularization (PCI) has been the main palliative treatment. Although long-term results are unknown, use of drug-eluting stents (DES) has been shown to have favorable outcome when used in heart transplant patients for treatment of focal lesions in CAV. We report the case of a 77-year-old male who presented with restenosis secondary to DES stent fracture (SF) after treatment of CAV with sirolimus-eluting stents (SES).

Original languageEnglish (US)
Pages (from-to)120-123
Number of pages4
JournalCardiovascular Revascularization Medicine
Volume11
Issue number2
DOIs
StatePublished - Apr 1 2010

Fingerprint

Sirolimus
Stents
Allografts
Drug-Eluting Stents
Transplants
Percutaneous Coronary Intervention
Heart Transplantation
Palliative Care
Therapeutics

Keywords

  • Cardiac allograft vasculopathy
  • Drug-eluting stent
  • Restenosis
  • Stent fracture

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy. / Cilingiroglu, Mehmet; Chilakapati, Venkata; Dunlap, Stephanie Hope; Leesar, Massoud A.

In: Cardiovascular Revascularization Medicine, Vol. 11, No. 2, 01.04.2010, p. 120-123.

Research output: Contribution to journalArticle

Cilingiroglu, Mehmet ; Chilakapati, Venkata ; Dunlap, Stephanie Hope ; Leesar, Massoud A. / Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy. In: Cardiovascular Revascularization Medicine. 2010 ; Vol. 11, No. 2. pp. 120-123.
@article{9f0947611de54a818514b7feefdd23ec,
title = "Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy",
abstract = "Cardiac allograft vasculopathy (CAV) is the most common cause of long-term graft failure after heart transplantation. In the absence of a specific treatment for this condition, percutaneous coronary revascularization (PCI) has been the main palliative treatment. Although long-term results are unknown, use of drug-eluting stents (DES) has been shown to have favorable outcome when used in heart transplant patients for treatment of focal lesions in CAV. We report the case of a 77-year-old male who presented with restenosis secondary to DES stent fracture (SF) after treatment of CAV with sirolimus-eluting stents (SES).",
keywords = "Cardiac allograft vasculopathy, Drug-eluting stent, Restenosis, Stent fracture",
author = "Mehmet Cilingiroglu and Venkata Chilakapati and Dunlap, {Stephanie Hope} and Leesar, {Massoud A.}",
year = "2010",
month = "4",
day = "1",
doi = "10.1016/j.carrev.2009.08.001",
language = "English (US)",
volume = "11",
pages = "120--123",
journal = "Cardiovascular Revascularization Medicine",
issn = "1553-8389",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy

AU - Cilingiroglu, Mehmet

AU - Chilakapati, Venkata

AU - Dunlap, Stephanie Hope

AU - Leesar, Massoud A.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Cardiac allograft vasculopathy (CAV) is the most common cause of long-term graft failure after heart transplantation. In the absence of a specific treatment for this condition, percutaneous coronary revascularization (PCI) has been the main palliative treatment. Although long-term results are unknown, use of drug-eluting stents (DES) has been shown to have favorable outcome when used in heart transplant patients for treatment of focal lesions in CAV. We report the case of a 77-year-old male who presented with restenosis secondary to DES stent fracture (SF) after treatment of CAV with sirolimus-eluting stents (SES).

AB - Cardiac allograft vasculopathy (CAV) is the most common cause of long-term graft failure after heart transplantation. In the absence of a specific treatment for this condition, percutaneous coronary revascularization (PCI) has been the main palliative treatment. Although long-term results are unknown, use of drug-eluting stents (DES) has been shown to have favorable outcome when used in heart transplant patients for treatment of focal lesions in CAV. We report the case of a 77-year-old male who presented with restenosis secondary to DES stent fracture (SF) after treatment of CAV with sirolimus-eluting stents (SES).

KW - Cardiac allograft vasculopathy

KW - Drug-eluting stent

KW - Restenosis

KW - Stent fracture

UR - http://www.scopus.com/inward/record.url?scp=77949895316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949895316&partnerID=8YFLogxK

U2 - 10.1016/j.carrev.2009.08.001

DO - 10.1016/j.carrev.2009.08.001

M3 - Article

C2 - 20347805

AN - SCOPUS:77949895316

VL - 11

SP - 120

EP - 123

JO - Cardiovascular Revascularization Medicine

JF - Cardiovascular Revascularization Medicine

SN - 1553-8389

IS - 2

ER -